Florian Haller
Overview
Explore the profile of Florian Haller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agaimy A, Dermawan J, Haller F, Semrau S, Meidenbauer N, Stoehr R, et al.
Virchows Arch
. 2024 Aug;
485(5):805-813.
PMID: 39196362
With the increasing use of innovative next generation sequencing (NGS) platforms in routine diagnostic and research settings, the genetic landscape of uterine sarcomas has been dynamically evolving during the last...
2.
Krebs M, Haller F, Sporl S, Gerhard-Hartmann E, Utpatel K, Maurus K, et al.
Eur J Cancer
. 2024 Jun;
207:114144.
PMID: 38852290
Purpose: Providing patient access to precision oncology (PO) is a major challenge of clinical oncologists. Here, we provide an easily transferable model from strategic management science to assess the outreach...
3.
Ihle M, Heydt C, Schultheis A, Stohr R, Haller F, Herold S, et al.
Sci Rep
. 2024 Jun;
14(1):13069.
PMID: 38844820
Insertion mutations in exon 20 of the epidermal growth factor receptor gene (EGFR exon20ins) are rare, heterogeneous alterations observed in non-small cell lung cancer (NSCLC). With a few exceptions, they...
4.
Schmidt C, Stohr R, Dimitrova L, Beckmann M, Rubner M, Fasching P, et al.
J Mol Diagn
. 2024 May;
26(7):624-637.
PMID: 38697471
In precision oncology, reliable testing of predictive molecular biomarkers is a prerequisite for optimal patient treatment. Interlaboratory comparisons are a crucial tool to verify diagnostic performance and reproducibility of one's...
5.
Eschbacher K, Tran Q, Moskalev E, Jenkins S, Fritchie K, Stoehr R, et al.
Brain Pathol
. 2024 Mar;
34(6):e13256.
PMID: 38523251
Meningeal solitary fibrous tumors (SFT) are rare and have a high frequency of local recurrence and distant metastasis. In a cohort of 126 patients (57 female, 69 male; mean age...
6.
Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing
Schlieben L, Carta M, Moskalev E, Stohr R, Metzler M, Besendorfer M, et al.
J Mol Diagn
. 2024 Feb;
26(5):387-398.
PMID: 38395409
Small blue round cell sarcomas (SBRCSs) are a heterogeneous group of tumors with overlapping morphologic features but markedly varying prognosis. They are characterized by distinct chromosomal alterations, particularly rearrangements leading...
7.
Togel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136436
Molecular Tumor Boards (MTBs) converge state-of-the-art next-generation sequencing (NGS) methods with the expertise of an interdisciplinary team consisting of clinicians, pathologists, human geneticists, and molecular biologists to provide molecularly informed...
8.
Kastner A, Kron A, Berg N, Moon K, Scheffler M, Schillinger G, et al.
Lancet Reg Health Eur
. 2023 Nov;
36:100788.
PMID: 38034041
Background: The national Network Genomic Medicine (nNGM) Lung Cancer provides comprehensive and high-quality multiplex molecular diagnostics and standardized personalized treatment recommendation for patients with advanced non-small cell lung cancer (aNSCLC)...
9.
Hohenberger P, Menge F, Hohenberger R, Kasper B, Marx A, Haller F, et al.
Cancer
. 2023 Sep;
130(1):51-59.
PMID: 37751183
Objectives: The development of desmoid tumors (DT) is associated with trauma, which is an aspect with medicolegal relevance. The objective of this study was to analyze the proportion and type...
10.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, et al.
Int J Hyperthermia
. 2023 Aug;
40(1):2248424.
PMID: 37611915
Introduction: Neoadjuvant chemotherapy and radiotherapy for the management of soft tissue sarcomas (STS) are still preferably delivered sequentially, with or without concurrent hyperthermia. Concurrent delivery of chemo-, radio- and thermotherapy...